Pliant Therapeutics logo

Pliant Therapeutics Share Price (NASDAQ: PLRX)

$1.64

0.02

(1.23%)

Last updated on

Check the interactive Pliant Therapeutics Stock chart to analyse performance

Pliant Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.55
    Today's High:$1.64

    Day's Volatility :5.49%

  • 52 Weeks Low:$1.10
    52 Weeks High:$16.10

    52 Weeks Volatility :93.17%

Pliant Therapeutics Stock Returns

PeriodPliant Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
13.54%
3.6%
0.0%
6 Months
18.48%
-7.7%
0.0%
1 Year
-87.21%
-12.6%
0.0%
3 Years
-91.95%
9.5%
-4.7%

Pliant Therapeutics Inc Key Stats

Check Pliant Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.62
Open
$1.6
Today's High
$1.64
Today's Low
$1.55
Market Capitalization
$100.7M
Today's Volume
$517.8K
52 Week High
$16.1
52 Week Low
$1.1001
Revenue TTM
$0.0
EBITDA
$-218.0M
Earnings Per Share (EPS)
$-3.38
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-67.55%

Stock Returns calculator for Pliant Therapeutics Stock including INR - Dollar returns

The Pliant Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pliant Therapeutics investment value today

Current value as on today

₹17,624

Returns

₹82,376

(-82.38%)

Returns from Pliant Therapeutics Stock

₹87,660 (-87.66%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Pliant Therapeutics Stock

-35%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Pliant Therapeutics Stock from India on INDmoney has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Pliant Therapeutics Inc

  • Name

    Holdings %

  • TANG CAPITAL MANAGEMENT LLC

    9.77%

  • BlackRock Inc

    8.54%

  • Deep Track Capital, LP

    6.43%

  • Morgan Stanley - Brokerage Accounts

    4.97%

  • Vanguard Group Inc

    4.89%

  • Blue Owl Capital Holdings LP

    4.84%

Analyst Recommendation on Pliant Therapeutics Stock

Rating
Trend

Buy

    95%Buy

    5%Hold

    0%Sell

Based on 20 Wall street analysts offering stock ratings for Pliant Therapeutics(by analysts ranked 0 to 5 stars)

Pliant Therapeutics Share Price Target

What analysts predicted

Upside of 80.31%

Target:

$2.96

Current:

$1.64

Pliant Therapeutics share price target is $2.96, a slight Upside of 80.31% compared to current price of $1.64 as per analysts' prediction.

Pliant Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, PLRX stock has moved up by 12.8%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 4.83M → 2.27M (in $), with an average decrease of 53.1% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -56.16M → -43.3M (in $), with an average increase of 29.7% per quarter
  • PLRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 157.6%
  • PLRX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 203.6%

Pliant Therapeutics Technicals Summary

Sell

Neutral

Buy

Pliant Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Pliant Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Pliant Therapeutics Inc logo
11.99%
18.48%
-87.21%
-91.95%
-93.46%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325, a phase 1-ready program for treatment of the muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Organization
Pliant Therapeutics
Employees
171
CEO
Dr. Bernard Coulie M.B.A., M.D., Ph.D.
Industry
Health Technology

Key Management of Pliant Therapeutics Inc

NameTitle
Dr. Bernard Coulie M.B.A., M.D., Ph.D.
President, CEO & Director
Dr. Keith Lamont Cummings M.B.A., M.D.
Chief Financial Officer
Mr. Johannes P. Hull J.D.
Chief Business Officer
Dr. Eric A. Lefebvre M.D.
Chief Medical Officer
Dr. Rik Derynck Ph.D.
Scientific Founder & Member of Scientific Advisory Board
Mr. Dean Sheppard M.D.
Scientific Founder & Member of Scientific Advisory Board
Mr. Bill DeGrado Ph.D.
Scientific Founder & Member of Scientific Advisory Board
Mr. Hal Chapman M.D.
Scientific Founder & Member of Scientific Advisory Board
Ms. Delphine Imbert Ph.D.
Chief Technical Officer
Mr. Christopher S. Keenan
Vice President of Investor Relations & Corporate Communications

Important FAQs about investing in PLRX Stock from India :

What is Pliant Therapeutics share price today?

Pliant Therapeutics share price today is $1.64 as on at the close of the market. Pliant Therapeutics share today touched a day high of $1.64 and a low of $1.55.

What is the 52 week high and 52 week low for Pliant Therapeutics share?

Pliant Therapeutics share touched a 52 week high of $16.10 and a 52 week low of $1.10. Pliant Therapeutics stock price today i.e. is closed at $1.64, lower by 89.81% versus the 52 week high.

How to invest in Pliant Therapeutics Stock (PLRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pliant Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pliant Therapeutics Shares that will get you 0.9146 shares as per Pliant Therapeutics share price of $1.64 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Pliant Therapeutics Stock (PLRX) from India?

Indian investors can start investing in Pliant Therapeutics (PLRX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Pliant Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Pliant Therapeutics share’s latest price of $1.64 as on August 30, 2025 at 1:29 am IST, you will get 6.0976 shares of Pliant Therapeutics. Learn more about fractional shares .

What are the returns that Pliant Therapeutics has given to Indian investors in the last 5 years?

Pliant Therapeutics stock has given -93.46% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?